|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Unaffiliated investments at acquisition cost | ||||||||||||||
| Affiliated investments at acquisition cost | ||||||||||||||
| Controlled investments at acquisition cost | ||||||||||||||
| Total acquisition cost | ||||||||||||||
| Unaffiliated investments at market value | ||||||||||||||
| Affiliated investments at market value | ||||||||||||||
| Controlled investments at market value | ||||||||||||||
| Total Market value (Note 6) | ||||||||||||||
| Foreign currency at value (cost $2,629 and $3,235) | ||||||||||||||
| Receivable from dividends and interest | ||||||||||||||
| Investment securities: | ||||||||||||||
| Investment, cost | ||||||||||||||
| Investment, Unaffiliated Issuer | ||||||||||||||
| Investment, Affiliated Issuer | ||||||||||||||
| Investment, Affiliated Issuer, Controlled | ||||||||||||||
| Investment, Controlled | ||||||||||||||
| Total investment, cost | ||||||||||||||
| Investments, market value, total | ||||||||||||||
| Investment, Unaffiliated Issuer | ||||||||||||||
| Investment, Affiliated Issuer | ||||||||||||||
| Investment, Affiliated Issuer, Controlled | ||||||||||||||
| Investment, Controlled | ||||||||||||||
| Total investments, market value, total | ||||||||||||||
| Foreign currency at value (cost $0 and $2,629) | ||||||||||||||
| Receivable for securities sold | ||||||||||||||
| Receivable from dividends and interest | ||||||||||||||
| Other assets | ||||||||||||||
| Total Assets | ||||||||||||||
| Payable to affiliates (Note 4) | ||||||||||||||
| Payable to affiliates (Note 2) | ||||||||||||||
| Trustees’ fees payable | ||||||||||||||
| Directors’ fees payable (Note 2) | ||||||||||||||
| Directors’ fees payable | ||||||||||||||
| Deferred directors’ fees payable (Note 2) | ||||||||||||||
| Consulting fee payable | ||||||||||||||
| Accrued taxes | ||||||||||||||
| Accrued expenses and other payables | ||||||||||||||
| Total Liabilities | ||||||||||||||
| NET ASSETS | ||||||||||||||
| Net Assets consist of: | ||||||||||||||
| Common Stock, par value $0.001 per share 100,000,000 shares authorized | ||||||||||||||
| Paid-in-capital | ||||||||||||||
| Total distributable earnings (loss) | ||||||||||||||
| Shares of Common Stock outstanding | ||||||||||||||
| NET ASSETS | ||||||||||||||
| Shares of Common Stock outstanding (in shares) | ||||||||||||||
| Shares of Treasury Stock outstanding (in shares) | ||||||||||||||
| Total Shares of Common Stock outstanding (in shares) | ||||||||||||||
| Net asset value per share (Note 2) (in dollars per share) | ||||||||||||||
Loading...